☆ 4.6 Meeting Abstract

A phase I trial of the combination of dasatinib and lapatinib

MOLECULAR CANCER THERAPEUTICS (2009)

Get Full Text
Add to Collection

Journal

MOLECULAR CANCER THERAPEUTICS
Volume 8, Issue 12, Pages -

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1535-7163.TARG-09-B56

Keywords

-

Categories

Oncology

Funding

  1. Glaxo Smith Kline
  2. Bristol Myers Squibb

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.